SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-21-000506
Filing Date
2021-02-02
Accepted
2021-02-02 17:16:42
Documents
2
Period of Report
2021-02-01

Document Format Files

Seq Description Document Type Size
1 form3-02022021_020210.html 3  
1 form3-02022021_020210.xml 3 3023
2 ex24-02022021_020212.htm EX-24 38578
  Complete submission text file 0001415889-21-000506.txt   43014
Mailing Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 343 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-577-3600
VistaGen Therapeutics, Inc. (Issuer) CIK: 0001411685 (see all company filings)

IRS No.: 205093315 | State of Incorp.: NV | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12119 CECILIA CT KINGSVILLE MD 21087
Business Address
Ginski Mark J (Reporting) CIK: 0001843460 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37761 | Film No.: 21582647